SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

Amicus Therapeutics Reaffurns FY2020 Sales Guidance of $250M-260M

Benzinga · 03/02/2020 12:11